[High intensity aerobic interval training improves peak oxygen consumption in patients with metabolic syndrome: CAT].
BACKGROUND
A number of cardiovascular risk factors characterizes the metabolic syndrome: insulin resistance (IR), low HDL cholesterol and high triglycerides. The aforementioned risk factors lead to elevated levels of abdominal adipose tissue, resulting in oxygen consumption deficiency.


OBJECTIVE
To verify the validity and applicability of using high intensity interval training (HIIT) in subjects with metabolic syndrome and to answer the following question: Can HIIT improve peak oxygen consumption?


METHODS
The systematic review "Effects of aerobic interval training on exercise capacity and metabolic risk factors in individuals with cardiometabolic disorders" was analyzed.


RESULTS
Data suggests high intensity aerobic interval training increases peak oxygen consumption by a standardized mean difference of 3.60 mL/kg-1/min-1 (95% confidence interval, 0.28-4.91).


CONCLUSIONS
In spite of the methodological shortcomings of the primary studies included in the systematic review, we reasonably conclude that implementation of high intensity aerobic interval training in subjects with metabolic syndrome, leads to increases in peak oxygen consumption.
Escuela de Kinesiología de la Universidad Santo Tomás, Santiago, Chile; Centro de Ejercicio Adaptado, Santiago, Chile. Address: Ejército 146, Santiago, Chile. Email: alexisespinozasa@santotomas.cl.
Alexis
A
Espinoza Salinas
Universidad de Santiago, Chile.
Raúl
R
Aguilera Eguía
Universidad de Santiago, Chile; Centro de Ejercicio Adaptado, Santiago, Chile.
Cristian
C
Cofre Bolados
Escuela de Kinesiología de la Universidad Santo Tomás, Santiago, Chile.
Edson
E
Zafra Santos
Escuela de Kinesiología de la Universidad Santo Tomás, Santiago, Chile.
Gustavo
G
Pavéz Von Martens
D002318:Cardiovascular Diseases / Q000209:etiology; D005081:Exercise Therapy / Q000379:methods*; D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000503:physiopathology / Q000628:therapy*; D010101:Oxygen Consumption / Q000502:physiology*; D012307:Risk Factors